Abstract-Vascular reactivity is reflected by blood biomarkers and noninvasive vascular function measurement. The relation of biomarkers to flow-mediated dilation and peripheral arterial tonometry in the general population is little understood. In 5000 individuals (mean age, 56Ϯ11 years; age range, 35-74 years; 49% women) of the population-based Gutenberg Health Study we simultaneously assessed 6 biomarkers of cardiovascular function (midregional proadrenomedullin [MR-proADM], midregional pro atrial natriuretic peptide [MR-proANP], N-terminal pro B-type natriuretic peptide, copeptin, C-terminal proendothelin 1, and neopterin) in relation to flow-mediated dilation and peripheral arterial tonometry. Strongest partial correlations (adjusted for age and sex) were observed for baseline pulse amplitude with MR-proADM (rϭ0.13) and MR-proANP (rϭϪ0.13); hyperemic response variables showed the highest correlation for MR-proADM and peripheral arterial tonometry ratio (rϭϪ0.14). In multivariable linear regression models, strongest associations with baseline vascular function were observed for MR-proANP with baseline pulse amplitude 1 Early detection of vascular impairment before clinically manifest disease has been the goal of preventive efforts.
V ascular dysfunction has been shown to be a critical intermediate phenotype of atherosclerotic cardiovascular events. 1 Early detection of vascular impairment before clinically manifest disease has been the goal of preventive efforts. 2, 3 Methods applied for screening of vascular dysfunction at the population level need to be noninvasive or minimally invasive. Most popular screening methods used recently are composed of the determination of flow-mediated dilation (FMD) of the brachial artery and peripheral arterial tonometry (PAT). [4] [5] [6] FMD reflects conduit artery reactivity, 7 and PAT represents microvascular status. 8 Both measures are modestly correlated with coronary endothelial function, 9, 10 and prospective data have remained controversial. 2, 3 Another approach to assess vascular status is the measurement of circulating biomarkers that may directly mirror vascular activation. Established and novel vasoactive peptides or their more stable precursors are composed of midregional proadrenomedullin (MR-proADM), midregional proatrial natriuretic peptide (MR-proANP), N-terminal pro-B-type natriuretic peptide (Nt-proBNP), copeptin as the C-terminal (CT) part of the arginine vasopressin prohormone, CT proendothelin 1, and neopterin. Most of these blood biomarkers have been correlated with measures of vascular function in humans. [11] [12] [13] [14] [15] These circulating biomarkers represent diverse protective and vasoaggressive mechanisms. The natriuretic peptides MR-proANP and Nt-proBNP, as well as MR-proADM, effectively control blood pressure and plasma volume and have been shown to be indicators of cardiovascular risk and mortality in initially healthy individuals. 16, 17 The antidiuretic hypothalamic hormone vasopressin regulates osmotic homeostasis through water retention in the kidneys and acts directly on vascular smooth muscle cells. 18 Endothelin 1 is a potent paracrine vasoconstrictor produced predominantly by endothelial cells. 19 The pteridine derivative neopterin is a marker of monocyte activation and mirrors elevated inflammatory states and vascular oxidative stress. 20, 21 Pathophysiologically, these biomarkers are strongly related to vascular homeostasis and reactivity.
The relation of the biomarker panel representing distinct vascular pathways with FMD and PAT in a large, populationbased sample is less well established. The aim of our study, therefore, was to directly compare 6 circulating vasoactive peptides with arterial reactivity in a cross-sectional sample of the Gutenberg Health Study.
Methods

Study Participants
We determined noninvasive measures of vascular function in the first 5000 individuals of the Gutenberg Health Study, a population-based cohort of individuals of European descent incepted in 2007 at the Department of Medicine 2, University Medical Center Mainz. The sample was composed of randomly selected individuals within a 10-year age strata from 35 to 74 years. Details on study inclusion and cardiovascular risk factor assessment have been published earlier. 6 In brief, during a clinic visit at the Center for Cardiovascular Prevention at Johannes Gutenberg University Mainz, study participants undergo standardized computer-assisted interviews on cardiovascular risk factors, lifestyle, and socioeconomic status. Standard anthropometric data are collected. Medications are recorded by self-report and from bottles and packages the participants are asked to bring to the study center. We used the following definitions for classical cardiovascular risk factors. Smoking status was composed of nonsmokers (never smokers and former smokers) and smokers. The diagnosis of diabetes mellitus was based on individuals reporting a physician diagnosis of diabetes mellitus or a fasting blood glucose concentration of Ն126 mg/dL after at least an 8-hour fasting period or a blood glucose level of Ն200 mg/dL. Dyslipidemia was diagnosed from a physician diagnosis of dyslipidemia or a lowdensity lipoprotein/high-density lipoprotein ratio of Ͼ3.5. Antihypertensive drug treatment, a mean systolic blood pressure of Ն140 mm Hg, or a mean diastolic blood pressure of Ն90 mm Hg led to the diagnosis of hypertension. Family history of myocardial infarction was defined as myocardial infarction of male first-degree relatives until the age of 60 years or female first-degree relatives until the age of 65 years. Self-reported coronary artery disease, myocardial infarction, heart failure, or stroke indicated prevalent cardiovascular disease.
The study has been approved by the local ethics committee; all of the participants provided written, informed consent. All of the authors have read and approved the article as written.
Flow-Mediated Dilation
FMD of the brachial artery after a 5-minute upper arm occlusion was measured under standardized conditions according to guidelines. 22 Diameter measurements of the brachial artery were performed on 2D high-resolution ultrasound images recorded on a Philips HD11XE CV ultrasound machine (Philips, Best, Netherlands) with an L12-5 (38 mm) linear array broadband probe. Diameters were measured offline using the commercially available Brachial Analyzer software tool, version 5.0 (Medical Imaging Applications LLC, Iowa City, IA). The means of 3 measurements at baseline and at 60 seconds after cuff release were taken for analysis. Of the 5000 consecutive individuals, 117 FMD cases were missing because of measurement errors and 119 cases were excluded from analysis because brachial diameter before or after was Ͻ2.4 mm or Ͼ6.5 mm or FMD was Ͻ0% or Ͼ25%.
Peripheral Arterial Tonometry
We used the Endo-PAT2000 (Itamar Medical, Caesarea, Israel) finger tip device to acquire the pneumatic pulse amplitude of the right index finger with the left index finger serving as a control. Results were automatically calculated using an optimized algorithm. 5 The first 336 consecutive data sets were missing because of technical transfer problems. A total of 189 studies were excluded because of noisy signal, inaccurate occlusion duration, or arterial pulse breakthrough during occlusion. In 96.2% we achieved highquality data.
FMD and PAT were performed simultaneously in a single examination by technicians trained according to protocol and with continuing quality assessment. Further details and quality control data, which showed good reproducibility of the 2 methods in the Gutenberg Health Study, are available in Reference 6.
Biomarker Measurement
Fasting blood was taken before vascular function measurement. Samples were aliquotted and stored at Ϫ80°C immediately after blood draw. We used routine laboratory methods for blood glucose and lipid measurements. Details of vascular biomarker determination have been reported earlier. 17 In brief, we measured plasma (MRproADM, MR-proANP, copeptin, CT proendothelin 1, and neopterin) and serum (Nt-proBNP) biomarkers using commercially available assays. Reproducibility was good, with all of the coefficients of variation (intra-assay and interassay) Ͻ5% (please see Table S1 , available in the online-only Data Supplement). Neopterin was missing in 1028 individuals because of limited sample volume and, thus, did not enter random forest analyses.
Statistical Methods
Data were analyzed for the total sample of 5000 individuals and stratified by sex. Available case analysis was performed. Skewed variables including all of the biomarkers were logarithmically transformed to achieve near normal distribution. Spearman rank correlation coefficients were calculated for biomarkers, vascular function parameters, and classic cardiovascular risk factors. Partial Spearman rank correlations were determined for biomarkers and measures of vascular function adjusted for age and sex. In linear regression models, biomarkers were related to vascular function parameters per 1-SD increase. Models were adjusted for age and sex, as well as for age, sex, and classic cardiovascular risk factors (body mass index, diabetes mellitus, current smoking, logarithmically transformed pulse pressure, dyslipidemia, and a positive family history of myocardial infarction). To account for renal function we performed secondary analyses adjusting for creatinine concentrations. To avoid confounding by prevalent cardiovascular disease, multivariable-adjusted models excluding individuals with manifest cardiovascular disease and heart failure were computed. Because some antihypertensive drugs and statins may affect vascular function, we also examined multivariable models adjusted for the use of ␤-blockers, angiotensin-converting enzyme inhibitors/angiotensin II type 2 receptor blockers, and dihydropyridine-type calcium channel blockers, as well as statin treatment, in secondary analyses. As a statistical significance threshold, PϽ0.05 was used for the current analyses. To account for multiple testing we performed a Bonferroni correction for the number of tests applied in each analysis, that is, the number of biomarkers. P values provided in the Results section have been adjusted and can be interpreted at the 0.05 level.
For statistical calculations we used R software, version 2.13.0 (R Foundation for Statistical Computing, Vienna, Austria; http://www.R-project.org).
Results
Details on the characteristics of the total study sample and stratified by sex are presented in Table 1 . The mean age in the cohort was 55.5Ϯ10.9 years; half of the sample was female. At the same mean age, cardiovascular risk factors were more frequent in men except for a positive family history of myocardial infarction, which tended to be more common in women 18.4% versus 17.0% in men. Women showed lower baseline pulse amplitude and smaller brachial artery diameters compared with men, and hyperemic response seemed to be more pronounced in women. MR-proADM and CT proendothelin 1 concentrations were not different between sexes (median, 0.46 nmol/L and 59.0 pmol/L, respectively, for the total sample). The natriuretic peptides MR-proANP and NtproBNP tended to be higher in women, whereas copeptin and neopterin revealed lower plasma levels in women.
Partial Spearman rank correlations between biomarkers and vascular function measures showed moderate relations Continuous variables are described by median and 25th and 75th percentile, if they had a skewed distribution ( skewness Ͼ1). Normally distributed variables are presented as mean values and SD. Categorical variables are described through relative and absolute frequencies. LDL indicates low-density lipoprotein; HDL, high-density lipoprotein; ACE, angiotensin-converting enzyme; FMD, flow-mediated dilation; PAT, peripheral arterial tonometry; MR-proADM, midregional proadrenomedullin; MR-proANP, midregional proatrial natriuretic peptide; Nt-proBNP, N-terminal pro-B-type natriuretic peptide; CT, C-terminal. Blood pressure and heart rate measurements were taken before noninvasive vascular function measurement. Prevalent cardiovascular disease contains selfreported coronary artery disease, myocardial infarction, heart failure, or stroke.
for MR-proADM with baseline pulse amplitude (rϭ0.13) and PAT ratio (rϭϪ0.14), as well as for MR-proANP with baseline pulse amplitude (rϭϪ0.13; Figure) . Highest correlation coefficients for FMD measures were rϭϪ0.074 for MR-proANP and brachial artery diameter and rϭϪ0.045 for MR-proADM and FMD. Overall, correlations were modest but significant at the 0.05 level. Correlation coefficients between the different blood biomarkers, classic risk factors, and noninvasive vascular function measures are provided in the online-only Data Supplement (Table S2) .
In multivariable linear regression models ( Pϭ0.015) with brachial artery diameter. A switch in the sign of MR-proADM coefficients for baseline pulse amplitude and brachial artery diameter in multivariable-adjusted models was observed after adding body mass index to the model. The change in sign indicates cross-correlations and potential interactions. For hyperemic response variables, the association remained statistically significant for CT-proendothelin (Ϫ0.025 [Ϫ0.043 to Ϫ0.008]; Pϭ0.00094) with the PAT ratio. Risk factors combined with information on biomarker concentrations explained between 14% (MR-proANP and PAT ratio) and 59% (neopterin and brachial artery diameter) of the variation of the respective vascular function measures. Biomarkers alone only accounted for 0.01% (MR-proANP and brachial artery diameter) and Յ10.80% (copeptin and brachial artery diameter) of the variation.
Discussion
In our contemporary population-based cohort we observed weak-to-moderate associations of circulating vascular biomarkers with noninvasive vascular function measures. In comparative analyses, MR-proADM and the natriuretic peptides were the strongest correlates of both PAT and brachial artery function other than sex, body mass index, and age. CT proendothelin 1 remained related to PAT ratio in multivariable-adjusted analyses. In general, relations were stronger with baseline vascular function parameters compared with hyperemic response. Overall, the amount of variability of vascular function measures explained by circulating biomarkers was small.
We compared all of the cardiovascular risk factors and circulating biomarkers. Sex, body mass index, and age were the strongest correlates of noninvasive vascular function. MR-proADM and the natriuretic peptides MR-proANP and Nt-proBNP provided the most additional information and were fairly consistently related to vascular function across the spectrum of biomarkers investigated.
Vascular impairment is central to cardiovascular disease. Noninvasive assessment of early vascular dysfunction might help to identify individuals at risk for incident cardiovascular disease and support prevention. Our data may improve the understanding of the cross-sectional relations of the measured biomarkers and vascular function. As expected, higher MRproADM concentrations were related to worse vascular function in age-and sex-adjusted models, that is, larger brachial artery diameter and baseline pulse amplitude and impaired response to hyperemia. MR-proADM reflects endotheliumdependent, as well as endothelium-independent, vasoreactivity, because adrenomedullin exerts its action through NOdependent mechanisms 23, 24 but mainly through cAMP. 25 Importantly, increases in cAMP lead to substantial inhibition of vascular superoxide production, which also has been shown to stimulate endothelin 1 production in endothelial and smooth muscle cells. [26] [27] [28] These latter mechanisms may provide insights into vascular function beyond NO response.
Because of their physiological actions, natriuretic peptides capture endothelium-dependent, NO-mediated vasoreactivity, as well as indirect vasodilative effects through activation of the cyclic guanosine monophosphate cascade. 29 An association of an atrial natriuretic peptide precursor and FMD has been reported earlier. 12 We have examined the reliably measurable midregional fragment of the prohormone and can confirm the findings of the Framingham Heart Study and extend the knowledge toward an association with peripheral arterial function. MR-proANP was positively associated with hyperemic response. The phenomenon of higher natriuretic peptide levels with better vascular function has been described before and may be attributed to beneficial vasodilatory properties in normal physiology and as a compensatory mechanism in disease. 30, 31 Similar to the experimental setting, atrial natriuretic peptide seemed to be the more potent vasodilator and more closely related to vascular reactivity in our current analyses compared with Nt-proBNP as an indicator of B-type natriuretic peptide action. 32 A stronger correlation with MRproANP may indicate that BNP rather represents cardiac function, whereas MR-proANP might more closely mirror vascular reactivity. An interesting finding was the association of CTproendothelin with PAT ratio as an indicator of microvascular function. No correlation with baseline pulse amplitude could be shown, although a significant correlation between baseline function and PAT ratio is known. 6 NO belongs to a variety of physiological inhibitors of endothelin 1 synthesis. 33 Elevated shear stress during reactive hyperemia after suprasystolic arterial occlusion is characterized by increased NO generation in healthy endothelial cells. In our sample, higher CT proendothelin 1 was related to lower hyperemic microvascular response and may, thus, reflect impaired capability of stimulated endothelial NO production not overt at baseline, when no relevant correlation between peripheral pulse amplitude and the biomarker was seen. Alternatively, endothelin has been shown to be a strong stimulator of vascular superoxide production, which may reduce endothelial NO bioavailability because of its rapid bimolecular reaction with superoxide. 34 Comparing circulating vascular function biomarkers, different associations were observed with baseline and hyperemic response variables in the 2 vascular beds. Although NO bioavailability is central to both reported noninvasive vascular function measures, 35, 36 basal tone and reactivity to ischemia and subsequent hyperemia are regulated by many other factors produced by endothelial and smooth muscle cells. Circulating biomarkers may act through a large variety of mechanisms affecting blood pressure, vascular volume, vascular tone, and long-term vascular homeostasis, which is not directly correlated with the reaction to ischemia and hyperemia. Overall, MR-proADM and the natriuretic peptides seemed to be most closely related to vascular function measures. Adrenomedullin has been described as more potent in vascular function regulation in the specific clinical setting of congestive heart failure, 37 an observation that is not clearly supported by our findings on circulating intrinsic biomarkers, because differences in the strength of associations between both markers were minor. Additional investigations are necessary to provide more insights into differences of adrenomedullin and atrial natriuretic peptide as regulators of vascular function.
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Limitations
A limitation of our study is the single measurement of vascular function and biomarkers, which does not account for intraindividual variability and changes over time with potential prognostic significance. With cross-sectional data we cannot draw final conclusions toward the clinical applicability of biomarker measurements compared with noninvasive vascular function. In addition, measurements were performed in individuals in a stable condition. Correlations between vascular function and biomarkers may profoundly differ in the setting of acute cardiovascular disease. Furthermore, our analyses were exploratory, and confirmation of our observations in independent samples is necessary to rule out bychance findings.
Among the strengths of our investigation counts the availability of data on a broad age range of individuals at risk for cardiovascular disease with simultaneous determination of 2 noninvasive vascular function tests and biomarker concentrations. Measurement at a single time point permits a direct comparison independent of many potential confounding conditions. Although a range of biomarkers has been assessed in relation to FMD in the past, 12 we now provide high-quality blood measurements on novel and more stable biomarkers in a contemporary sample. We can, thus, extend recent observations toward a different set of circulating markers with a direct pathophysiological relation to vascular tone and reactivity in 2 distinct noninvasive measures of vascular function.
Our study demonstrates that both blood biomarkers and noninvasive vascular function measures can be acquired under standardized conditions at a large scale. Crucial for the understanding of the value for prevention is the association with cardiovascular outcome. Results have been inconsistent for FMD. 2, 3 and large-scale data at the population level are lacking for PAT. For MR-proADM and MR-proANP, 17 initial data suggest potential relevance in population screening for susceptibility for cardiovascular disease and kidney function. 38 The next step will, thus, need to be the rigorous comparison of the prospective value of the vascular function markers for cardiovascular diseases in an early, potentially reversible state in the population. values. Risk factor adjustment was composed of age, sex, body mass index, diabetes mellitus, current smoking, logarithmically transformed pulse pressure, dyslipidemia, and a positive family history of myocardial infarction. FMD indicates flow-mediated dilation; PAT, peripheral arterial tonometry; MR-proADM, midregional proadrenomedullin; MR-proANP, midregional proatrial natriuretic peptide; Nt-proBNP, N-terminal pro-B-type natriuretic peptide; CT, C-terminal. Biomarker associations were comparable if stratified for sex (data not shown). Multivariable models accounting for renal function through adjustment for creatinine concentrations (Table S3 ) and common types of antihypertensive medication and statin therapy (Table S4 ) are provided in the online-only Data Supplement. The strength of association remained similar as compared with the main analyses. Regression results were similar when individuals with manifest cardiovascular disease were excluded from analyses (Table S5) .
Perspectives
Among a panel of circulating biomarkers of highly vasoactive mediators, we identified the novel biomarkers MR-proADM and MR-proANP as correlates of conduit artery and microvascular function in the general population. Whether the information on vascular status gained from a single blood biomarker measurement has a prognostic meaning for vascular function deterioration and incident cardiovascular events needs to be investigated in prospective studies. Provided are the intra-and inter-assay coefficients of variation (CV) in %. Provided are Spearman rank correlation coefficients and respective P values. BMI stands for body mass index, MI for myocardial infarction, and PAT for peripheral arterial tonometry. 
